Riskpilot← Back to searchSign inGet full accessCytely AB
ABActiveOrg 5593955593LundComputer programming activities · NACE 6210Est. 20225-9 employees
Revenue 2024
SEK 45K
-94% vs 2023
EBITDA margin
-1873.0%
-376% vs 2023
Equity ratio
89.0%
Financial strength
Net profit 2024
SEK -840K
-330% vs 2023
| Revenue | SEK 45K | -94% |
| EBITDA | SEK -843K | -376% |
| Net profit | SEK -840K | -330% |
| Total assets | SEK 5,3M | +2094% |
| Equity | SEK 4,7M | +2872% |
| Employees | — | — |
Legal name
Cytely AB
Org number
5593955593
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
7 september 2022
Share capital
SEK 25 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Nordenfelt, Erik Philip
Company purpose
Bolaget ska bedriva verksamhet inom bio-, medicin- och labbteknik samt därmed förenlig verksamhet.
Address
Lund
Email
philip@cytely.io
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 765 | 45 |
| Staff expenses | −855 | −486 |
| EBITDA | −177 | −843 |
| Depreciation & amort. | — | — |
| EBIT | −177 | −843 |
| Net financials | −18 | 3 |
| Profit before tax | −195 | −840 |
| Tax | — | — |
| Net profit | −195 | −840 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 242 | 5 304 |
| Equity | −170 | 4 721 |
| Long-term debt | 300 | 194 |
| Short-term debt | 112 | 390 |
| Total debt | 412 | 584 |
EBITDA margin
-1873.0%
This company
15.8%
Market median
-11954% vs market
20232024
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20232024
Return on equity
-17.8%
This company
18.4%
Market median
-197% vs market
20232024
Net profit margin
-1867.1%
This company
8.1%
Market median
-23151% vs market
20232024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20232024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Chief Auditor | Chief Auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cytely AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Johan Fredrik Fogelberg | Chief Auditor | 0 companies |
| Johannes Ragnvald Kumra Ahnlide | Board of Directors | 0 companies |
| Per Oscar Albin André | Board of Directors | 0 companies |
| Erik Philip Nordenfelt | Board of Directors | 0 companies |
| Merete Louise Lachmann | Board of Directors | 0 companies |
| Bill Pontus Nordenfelt | Chairman | 0 companies |
| Lasse Kalle Juhani Lehtinen | Board of Directors | 0 companies |